Answers are grounded in this paper and cite their sources.
A cooperative Rh(II)/chiral phosphoric acid (CPA) catalytic system enables highly diastereoselective alkylation of tryptophan derivatives and Trp-containing peptides at both the N(1) and C(6) positions. The reaction exhibits substrate-controlled regioselectivity: unmodified tryptophan derivatives undergo N(1)-alkylation, whereas preinstallation of a phenyl directing group at C(2) switches the selectivity to C(6)-alkylation, with both modes proceeding with high stereocontrol (up to 99:1 dr). The reaction features mild conditions, low catalyst loading, and broad substrate tolerance, enables the late-stage N(1)-alkylation of di-, tri-, and tetrapeptides containing non-nucleophilic residues and the late-stage C(6)-alkylation of di- and tripeptides containing non-nucleophilic residues. Mechanistic studies support a plausible Rh/CPA cooperative catalytic cycle, with CPA-promoted keto–enol tautomerization proposed to govern stereoselectivity.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: